TP53 and cancer: Subsequent studies showed that both mutant and wild-type p53 can elicit a T cell response in HLA-A*02:01-transgenic and in peripheral blood T cells isolated from patients with cancer (Theobald et al. 1995, Tilkin et al. 1995).